BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 35836081)

  • 21. Optogenetics: opsins and optical interfaces in neuroscience.
    Adamantidis AR; Zhang F; de Lecea L; Deisseroth K
    Cold Spring Harb Protoc; 2014 Aug; 2014(8):815-22. PubMed ID: 25086025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BioLuminescent OptoGenetics in the choroid plexus: integrated opto- and chemogenetic control
    Klein E; Marsh S; Becker J; Andermann M; Lehtinen M; Moore CI
    Neurophotonics; 2024 Apr; 11(2):024210. PubMed ID: 38948888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bioluminescent Optogenetics: A Novel Experimental Therapy to Promote Axon Regeneration after Peripheral Nerve Injury.
    English AW; Berglund K; Carrasco D; Goebel K; Gross RE; Isaacson R; Mistretta OC; Wynans C
    Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281270
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Co-expressing fast channelrhodopsin with step-function opsin overcomes spike failure due to photocurrent desensitization in optogenetics: a theoretical study.
    Bansal H; Pyari G; Roy S
    J Neural Eng; 2022 Apr; 19(2):. PubMed ID: 35320791
    [No Abstract]   [Full Text] [Related]  

  • 25. A Very Bright Far-Red Bioluminescence Emitting Combination Based on Engineered Railroad Worm Luciferase and 6'-Amino-Analogs for Bioimaging Purposes.
    Viviani VR; Bevilaqua VR; de Souza DR; Pelentir GF; Kakiuchi M; Hirano T
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A New Highly Efficient Molecule for Both Optogenetic and Chemogenetic Control Driven by FRET Amplification of BioLuminescence.
    Bjorefeldt A; Murphy J; Crespo EL; Lambert GG; Prakash M; Ikefuama EC; Friedman N; Brown TM; Lipscombe D; Moore CI; Hochgeschwender U; Shaner NC
    bioRxiv; 2023 Dec; ():. PubMed ID: 37425735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Opto-chemogenetics with luminopsins: A novel avenue for targeted control of neuronal activity.
    Berglund K; Gross RE
    J Neurosci Res; 2020 Mar; 98(3):407-409. PubMed ID: 31157461
    [No Abstract]   [Full Text] [Related]  

  • 28. Coelenterazine-Type Bioluminescence-Induced Optical Probes for Sensing and Controlling Biological Processes.
    Jiang T; Song J; Zhang Y
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiac optogenetics.
    Entcheva E
    Am J Physiol Heart Circ Physiol; 2013 May; 304(9):H1179-91. PubMed ID: 23457014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Challenges for Therapeutic Applications of Opsin-Based Optogenetic Tools in Humans.
    Shen Y; Campbell RE; Côté DC; Paquet ME
    Front Neural Circuits; 2020; 14():41. PubMed ID: 32760252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optogenetic approaches to treat epilepsy.
    Wykes RC; Kullmann DM; Pavlov I; Magloire V
    J Neurosci Methods; 2016 Feb; 260():215-20. PubMed ID: 26072246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bioluminescence-driven optogenetic activation of transplanted neural precursor cells improves motor deficits in a Parkinson's disease mouse model.
    Zenchak JR; Palmateer B; Dorka N; Brown TM; Wagner LM; Medendorp WE; Petersen ED; Prakash M; Hochgeschwender U
    J Neurosci Res; 2020 Mar; 98(3):458-468. PubMed ID: 29577367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Translational PET applications for brain circuit mapping with transgenic neuromodulation tools.
    Boehm MA; Bonaventura J; Gomez JL; Solís O; Stein EA; Bradberry CW; Michaelides M
    Pharmacol Biochem Behav; 2021 May; 204():173147. PubMed ID: 33549570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Opsins for vision restoration.
    Simon CJ; Sahel JA; Duebel J; Herlitze S; Dalkara D
    Biochem Biophys Res Commun; 2020 Jun; 527(2):325-330. PubMed ID: 31982136
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Broad-Band Activatable White-Opsin.
    Batabyal S; Cervenka G; Ha JH; Kim YT; Mohanty S
    PLoS One; 2015; 10(9):e0136958. PubMed ID: 26360377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The treatment of neurological diseases under a new light: the importance of optogenetics.
    Kokaia M; Sørensen AT
    Drugs Today (Barc); 2011 Jan; 47(1):53-62. PubMed ID: 21373649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Restoring Function After Severe Spinal Cord Injury Through BioLuminescent-OptoGenetics.
    Petersen ED; Sharkey ED; Pal A; Shafau LO; Zenchak-Petersen J; Peña AJ; Aggarwal A; Prakash M; Hochgeschwender U
    Front Neurol; 2021; 12():792643. PubMed ID: 35126293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Viral-mediated transduction of auditory neurons with opsins for optical and hybrid activation.
    Richardson RT; Thompson AC; Wise AK; Ajay EA; Gunewardene N; O'Leary SJ; Stoddart PR; Fallon JB
    Sci Rep; 2021 May; 11(1):11229. PubMed ID: 34045604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optogenetic Modulation of Ion Channels by Photoreceptive Proteins.
    Tsukamoto H; Furutani Y
    Adv Exp Med Biol; 2021; 1293():73-88. PubMed ID: 33398808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeted expression of step-function opsins in transgenic rats for optogenetic studies.
    Igarashi H; Ikeda K; Onimaru H; Kaneko R; Koizumi K; Beppu K; Nishizawa K; Takahashi Y; Kato F; Matsui K; Kobayashi K; Yanagawa Y; Muramatsu SI; Ishizuka T; Yawo H
    Sci Rep; 2018 Apr; 8(1):5435. PubMed ID: 29615713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.